Journal

AMBOSS grounds its AI study copilot in its own peer-reviewed library — this Step 2 CK review tests how far that grounding holds, where reasoning support ends and answer delivery be...

AMBOSS made a deliberate, restrictive choice: rather than searching broadly, its AI draws only on a small, editorially curated set of sources. That trade-off is worth understanding...

A Stanford-Harvard evaluation using 100 real clinical cases ranked AMBOSS AI Mode first for safety among 31 systems tested. This is a genuinely more informative benchmark than an e...

Several platforms now describe themselves as evidence graded, but the term covers a genuinely wide range of different underlying approaches. This is a guide to what each one actual...

Vera reports 97.5% on USMLE, 84.9% on NEJM-AI and 62.2% on MedXpertQA. These are genuinely strong, company-reported numbers, and it is worth being precise about exactly what they d...

Vera says it searches more than 60 million papers, guidelines and care pathways. A genuinely large corpus is valuable, but corpus size and answer quality are not the same thing, an...

Vera applies its own evidence-grading logic before generating an answer, described as similar to the work of a guideline methodologist. The genuine question is what that grading ac...

OpenEvidence itself has described EvidenceGrade as a starting point meant to improve through feedback. That framing is an invitation to genuine, independent validation, not a finis...

iatroX's evidence hierarchy for UK point-of-care questions runs from authoritative national guidance through systematic reviews to individual trials, with clinical judgement determ...

A meta-analysis sits near the top of the evidence hierarchy for a reason, but the hierarchy is a route towards the likely best evidence, not an automatic quality verdict on any spe...

EvidenceGrade shares a name and a lineage with the GRADE framework, but a real-time system built for point-of-care speed cannot fully replicate what a deliberative, weeks-long expe...

Different clinical studies are not interchangeable data points. Averaging them into a single grade, however tempting for a clean interface, risks concealing exactly the disagreemen...